Coming soon — Purely Medspa, Back Bay · Boston
Field notes · Field notes

Botox side effects and droopy eyelid risk

Discover the side effects of Botox and how common a droopy eyelid really is, plus treatment options backed by FDA clinical trial data.

By Dr. Bella Brooks·6 min read·Updated Oct 2026Clinically reviewed
Purely Medspa editorial cover for Botox side effects and droopy eyelid risk.

What Botox is and how it works

You are considering Botox for frown lines or forehead wrinkles, but you have heard about the side effects of Botox, especially a droopy eyelid, and you want real numbers before booking. That is exactly what this article provides: specific incidence rates for ptosis and other side effects drawn from FDA clinical trial data and recent peer-reviewed studies, plus what to do if it happens.

Botox (onabotulinumtoxinA) is an FDA-approved neurotoxin that temporarily blocks nerve signals to the muscles responsible for expression lines. The FDA has approved Botox Cosmetic for three cosmetic indications: glabellar lines (frown lines), lateral canthal lines (crow's feet), and forehead lines. By blocking acetylcholine release at the neuromuscular junction, Botox prevents muscle contraction, and most side effects occur when the toxin diffuses beyond the intended target.

Common side effects of Botox injections

The most frequently reported side effects of Botox are mild and localized to the injection area:

  • Injection-site pain, swelling, bruising, and redness
  • Headache
  • Temporary facial weakness or paresis
  • Eyelid ptosis (drooping of the upper eyelid)
  • Skin tightness in the treated area

FDA clinical trial data shows headache occurred in 9% of patients treated for forehead lines (58 of 665), the most frequently reported reaction for that indication. For glabellar lines, the FDA label reports eyelid ptosis in 3% of patients (13 of 405), facial pain in 1%, facial paresis in 1%, and muscular weakness in 1%, all higher than placebo.

A retrospective study of 5,014 patients across six Italian centers found an overall adverse event rate of 5.99%, with mild bruising at 3%, temporary headache at 1.8%, and no severe adverse reactions. No cases of upper eyelid ptosis were observed among the 4,000 patients evaluated at follow-up.

Serious side effects and the FDA distant-spread warning

Botox carries an FDA boxed warning for distant spread of toxin effect, which can occur hours to weeks after injection regardless of dose. The warning applies to all botulinum toxin products.

Symptoms that warrant immediate medical attention include:

  • Generalized muscle weakness
  • Double or blurred vision
  • Drooping eyelids beyond the treated area
  • Trouble swallowing (dysphagia)
  • Breathing difficulty
  • Loss of bladder control

The FDA label notes that rare post-marketing reports have involved the cardiovascular system, some with fatal outcomes, and advises caution for patients with pre-existing cardiovascular disease or compromised respiratory function. Anaphylaxis and serum sickness have been reported rarely. These serious reactions are rare with cosmetic dosing, but knowing the warning signs means you can act quickly. At our clinic, we use only FDA-approved wrinkle relaxers sourced directly from manufacturers.

How common is a droopy eyelid after Botox?

Eyelid ptosis occurred in 3% of glabellar line patients (13 of 405) and 2% of forehead line patients (12 of 665) in FDA clinical trials, versus 0% with placebo. For crow's feet treatment, ptosis was not reported at a rate of 1% or higher.

Real-world rates depend heavily on who is injecting. A 2025 peer-reviewed study published in Dermatology Research and Practice found ptosis rates of 2.5 to 5.4% among inexperienced injectors, compared with 0.51 to 1% among experienced injectors.

A 2025 global pharmacovigilance analysis of 43,809 adverse event reports across four international databases found that facial paresis, ptosis, and asymmetry together accounted for 9.9% of all reports.

SourcePatient populationReported ptosis rate
FDA clinical trials (glabellar lines)405 patients3% (13 of 405)
FDA clinical trials (forehead + glabellar)665 patients2% (12 of 665)
2025 study (experienced injectors)Real-world practice0.51 to 1%
2025 study (inexperienced injectors)Real-world practice2.5 to 5.4%

Who is holding the syringe matters more than the product itself. Injector training and technique drive the difference between a sub-1% and a 5% ptosis rate.

Why Botox causes a droopy eyelid and how ptosis differs from brow ptosis

When Botox is injected near the brow, it can diffuse to the levator palpebrae superioris, the muscle that lifts the upper eyelid. When that muscle weakens, the lid droops. Clinically, this is called blepharoptosis: an eyelid positioned 1.5 to 2 mm below the scleral-corneal limbus, which can partially obstruct vision.

Brow ptosis is a lowered eyebrow caused by relaxation of the frontalis muscle. A dropped brow can make the eyelid look heavy even though the lid itself is functioning normally. In FDA forehead line trials, eyelid ptosis occurred in 2% of patients (12 of 665) and brow ptosis also in 2% (13 of 665).

The FDA label advises avoiding injection near the levator palpebrae superioris, particularly in patients with larger brow depressor complexes. Higher doses and lower injection points near the brow increase the risk of unintended diffusion. At our practice, how we approach Botox consultations includes reviewing your anatomy and planning injection points before any treatment begins.

How long a droopy eyelid lasts and what you can do about it

Ptosis usually becomes noticeable 3 to 14 days after injection and resolves spontaneously in approximately 3 months as the toxin's effect wears off. While it resolves on its own, a droopy eyelid can cause real distress during that wait.

Treatment options include apraclonidine 0.5% ophthalmic solution and oxymetazoline eye drops, which stimulate Müller's muscle to lift the upper eyelid by 1 to 2 mm. Other options include muscle exercises, vibrating devices, and in some cases pretarsal Botox injection techniques.

Contact your injector as soon as you notice drooping so eye drops can be prescribed and the situation monitored. The drops provide temporary relief and do not shorten the overall duration of the ptosis. They bridge the gap until the toxin naturally wears off.

Reducing your risk: injector experience and aftercare

Injector experience is the primary modifiable risk factor for ptosis. The peer-reviewed data shows experienced injectors achieve ptosis rates below 1%, compared with up to 5.4% for inexperienced ones.

Practical steps to reduce your risk:

  • Choose a nurse-practitioner or physician-led clinic where the same clinician plans and performs your treatment
  • Ask whether products are FDA-approved and sourced directly from the manufacturer
  • Discuss your full medical history, including any neuromuscular conditions
  • Avoid rubbing the treated area, lying flat, or exercising vigorously for the first 24 hours after treatment

Our zero-commission model means clinicians recommend only the treatment you need, and our no-pressure consultation gives you time to discuss risks without being pushed to inject the same day. Avoid discount or pop-up injection events, where injector familiarity with facial anatomy and follow-up care may be limited.

Takeaways

  • Eyelid ptosis occurred in 3% of glabellar line patients and 2% of forehead line patients in FDA clinical trials
  • Experienced injectors achieve ptosis rates below 1%, while inexperienced injectors see rates up to 5.4%
  • Ptosis typically appears 3 to 14 days after injection and resolves in about 3 months
  • Apraclonidine and oxymetazoline eye drops provide temporary relief while waiting for the toxin to wear off
  • The FDA boxed warning covers distant spread of toxin effect, which is rare with cosmetic dosing

Talk to a nurse-practitioner injector in Back Bay

FDA clinical trials put eyelid ptosis at 3% for glabellar lines and 2% for forehead lines, and experienced injectors bring that rate below 1%. The right injector makes most complications rare and manageable.

Our team at Purely Medspa is nurse-practitioner led and physician supervised, with board-certified clinicians who use only FDA-approved products sourced directly from manufacturers and document every treatment with standardized photography and written plans. You meet with the same injector who plans and performs your treatment, and there is no treating on consultation day unless you request it.

Schedule a no-pressure consultation at our Back Bay clinic to talk through your Botox options and side-effect questions with a qualified injector. Book your consultation today to review your medical history and receive a personalized treatment plan.

Frequently asked

How long does a droopy eyelid from Botox last?
A droopy eyelid from Botox typically appears 3 to 14 days after injection and resolves on its own within about 3 months as the toxin wears off. Some patients see improvement sooner, and eye drops such as apraclonidine can provide temporary lifting while you wait.
Can you prevent a droopy eyelid from Botox?
FDA clinical trial data shows eyelid ptosis occurred in 3% of patients treated for glabellar lines and 2% treated for forehead lines. In real-world practice, rates drop below 1% with experienced injectors but can rise to 5.4% among inexperienced ones. Injector skill is the single biggest variable.
What are the signs of a serious Botox reaction?
Contact your provider right away if you experience trouble swallowing, breathing difficulty, generalized muscle weakness, blurred or double vision, or loss of bladder control. These may indicate distant spread of the toxin and are covered by the FDA's boxed warning for all botulinum toxin products.
Can eye drops fix a droopy eyelid from Botox?
Apraclonidine 0.5% and oxymetazoline eye drops are the most common treatments. They stimulate Müller's muscle to lift the upper eyelid by 1 to 2 mm and provide temporary relief while the toxin effect naturally wears off over several weeks.
What is the difference between eyelid ptosis and brow ptosis from Botox?
Eyelid ptosis is the drooping of the upper eyelid itself, caused by toxin affecting the levator palpebrae superioris muscle. Brow ptosis is a lowered eyebrow, usually from relaxation of the frontalis muscle, which can make the eyelid look heavy even though the lid itself is functioning normally.
Dr. Bella Brooks
Medical Director & Aesthetic Physician

Dr. Bella Brooks is a medical aesthetics physician at Purely Medspa in Boston, focusing on facial aesthetics, injectables, treatment planning, and natural-looking aesthetic results.

Want your own number?

A free thirty-minute consult ends with a written map: your zones, your unit counts, and a total. No obligation to book anything.

Book a consult
Keep reading